(VIANEWS) - Roku (ROKU), The ONE Group Hospitality (STKS), DXP Enterprises (DXPE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Roku (ROKU)
46.7% sales growth and 7.28% return on equity
Roku, Inc., together with its subsidiaries, operates a TV streaming platform.
Roku's sales growth this year is anticipated to be 59.9% and 37% for next year.
Year-on-year quarterly revenue growth grew by 79%, now sitting on 2.03B for the twelve trailing months.
Volume
Today's last reported volume for Roku is 5223870 which is 34.33% below its average volume of 7955380.
News about Roku(ROKU) today
- According to today's article on Bloomberg Quint, "CNN+ already has agreements with Apple and Roku but it's hoping to close deals with other distributors before the launch, CNN Digital chief Andrew Morse said in an interview with Bloomberg TV's Emily Chang at the South by Southwest festival in Austin, Texas. "
Roku's sales growth for the next quarter is 46.7%. The company's growth estimates for the present quarter and the next is a negative 33.3% and negative -61.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.28%.
Volatility
Roku's last day, last week, and last month's current intraday variation average was 6.74%, 5.83%, and 3.92%, respectively.
Roku's highest amplitude of average volatility was 8.87% (day), 7.86% (last week), and 7.81% (last month), respectively.
Roku's Stock Yearly Top and Bottom Value
Roku's stock is valued at $103.85 at 11:22 EST, way below its 52-week low of $196.94.
Roku's Moving Average
Roku's worth is way below its 50-day moving average of $280.17 and way below its 200-day moving average of $341.49.Previous days news about Roku(ROKU)
- According to Bloomberg Quint on Thursday, 10 March, "In the face of a volatile market, she has stuck with stocks including Tesla Inc., Roku Inc. and a host of speculative bets backed by exciting ideas and much less exciting profits, if any at all. "
- According to Bloomberg Quint on Friday, 11 March, "RT America, the U.S. arm of the Russian-government-controlled TV channel, shut down after U.S. distributors including DirecTV and Roku dropped the network."
2. The ONE Group Hospitality (STKS)
42.5% sales growth and 53.94% return on equity
The ONE Group Hospitality, Inc., a hospitality company, develops, owns, and operates restaurants and lounges worldwide.
The ONE Group Hospitality's sales growth this year is anticipated to be 90.2% and 16% for next year.
Year-on-year quarterly revenue growth grew by 81.6%, now sitting on 238.1M for the twelve trailing months.
Volume
Today's last reported volume for The ONE Group Hospitality is 190661 which is 71.34% above its average volume of 111274.
The ONE Group Hospitality's sales growth for the next quarter is 42.5%. The company's growth estimates for the present quarter and the next is 250% and 160%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 53.94%.
Volatility
The ONE Group Hospitality's last day, last week, and last month's current intraday variation average was 7.21%, 4.12%, and 2.79%, respectively.
The ONE Group Hospitality's highest amplitude of average volatility was 9.57% (day), 6.93% (last week), and 6.17% (last month), respectively.
The ONE Group Hospitality's Stock Yearly Top and Bottom Value
The ONE Group Hospitality's stock is valued at $10.22 at 11:22 EST, way under its 52-week high of $16.44 and way above its 52-week low of $5.43.
The ONE Group Hospitality's Moving Average
The ONE Group Hospitality's value is way under its 50-day moving average of $12.30 and way below its 200-day moving average of $11.77.3. DXP Enterprises (DXPE)
19.3% sales growth and 3.45% return on equity
DXP Enterprises, Inc., together with its subsidiaries, engages in distributing maintenance, repair, and operating (MRO) products, equipment, and services to energy and industrial customers primarily in the United States and Canada.
DXP Enterprises's sales growth this year is expected to be 10% and 10.1% for next year.
Year-on-year quarterly revenue growth grew by 31.5%, now sitting on 1.05B for the twelve trailing months.
Volume
Today's last reported volume for DXP Enterprises is 53362 which is 55.81% below its average volume of 120769.
DXP Enterprises's sales growth for the next quarter is 19.3%. The company's growth estimates for the present quarter and the next is a negative 26.3% and 1050%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.45%.
Volatility
DXP Enterprises's last day, last week, and last month's current intraday variation average was 1.64%, 1.15%, and 1.51%, respectively.
DXP Enterprises's highest amplitude of average volatility was 2.66% (day), 4.50% (last week), and 3.82% (last month), respectively.
DXP Enterprises's Stock Yearly Top and Bottom Value
DXP Enterprises's stock is valued at $28.44 at 11:22 EST, way below its 52-week high of $36.26 and way higher than its 52-week low of $23.33.
DXP Enterprises's Moving Average
DXP Enterprises's worth is higher than its 50-day moving average of $26.98 and below its 200-day moving average of $30.11.4. Supernus Pharmaceuticals (SUPN)
9.4% sales growth and 10.76% return on equity
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States.
Supernus Pharmaceuticals's sales growth this year is expected to be 8.9% and 19% for next year.
Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 564.28M for the twelve trailing months.
Volume
Today's last reported volume for Supernus Pharmaceuticals is 462097 which is 0.77% below its average volume of 465683.
Supernus Pharmaceuticals's sales growth for the next quarter is 9.4%. The company's growth estimates for the present quarter and the next is a negative 50.9% and 236.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.76%.
Volatility
Supernus Pharmaceuticals's last day, last week, and last month's current intraday variation average was 2.32%, 3.74%, and 2.28%, respectively.
Supernus Pharmaceuticals's highest amplitude of average volatility was 4.35% (day), 6.10% (last week), and 4.20% (last month), respectively.
Supernus Pharmaceuticals's Stock Yearly Top and Bottom Value
Supernus Pharmaceuticals's stock is valued at $30.39 at 11:22 EST, way under its 52-week high of $34.50 and way higher than its 52-week low of $23.15.